paclitaxel has been researched along with Pulmonary Arterial Remodeling in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 8 (66.67) | 24.3611 |
| 2020's | 4 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Ceresnakova, M; Hudson, SP; Murray, D; Soulimane, T | 1 |
| Ates, I; Avci, R; Cilingiroglu, M; Dijkstra, J; Feldman, MD; Hoyt, T; Iliescu, C; Kose, G; Lendel, V; Marmagkiolis, K; McElroy, A; McIntosh, V; Mego, D; Milner, TE; Okutucu, S; Paixao, A; Park, J; Shaar, M | 1 |
| Bai, X; Cheng, S; Li, J; Li, S; Xi, J; Zhao, X | 1 |
| Cornelissen, A; Fernandez, R; Finn, AV; Fuller, D; Gadhoke, N; Guo, L; Jinnouchi, H; Kawai, K; Kawakami, R; Kolodgie, FD; Kuntz, S; Mori, M; Paek, KH; Ragheb, A; Sakamoto, A; Sato, Y; Torii, S; Virmani, R; Young, B | 1 |
| Asano, Y; Goto, W; Hatano, T; Hirakawa, K; Kashiwagi, S; Motomura, H; Ohira, M; Ohsawa, M; Takada, K; Takahashi, K; Takashima, T; Tanaka, S; Tomita, S | 1 |
| Saeki, T; Ueda, S | 1 |
| Endo, H; Nakajima, S; Nakamura, A; Noda, K; Nozaki, E; Takahashi, T | 1 |
| Karnabatidis, D; Katsanos, K; Kitrou, PM; Siablis, D; Spiliopoulos, S | 1 |
| Al-Tamari, HM; Capecchi, MR; Grimminger, F; Kojonazarov, B; Muecke, C; Pullamsetti, SS; Savai, R; Schermuly, RT; Sedding, D; Seeger, W; Teske, R; Weissmann, N | 1 |
| Böhm, M; Clever, YP; Cremers, B; Dietz, U; Hauschild, T; Kleber, FX; Scheller, B; Schulz, A; Waliszewski, M | 1 |
| Jing, L; Lü, J; Luo, X; Ning, Q; Tian, D; Wang, D; Wang, W; Xie, M; Zhang, S | 1 |
| Duderstadt, C; Figulla, HR; Goebel, B; Kretzschmar, D; Otto, S; Poerner, TC | 1 |
2 trial(s) available for paclitaxel and Pulmonary Arterial Remodeling
| Article | Year |
|---|---|
Paclitaxel-coated balloon angioplasty versus drug-eluting stenting for the treatment of infrapopliteal long-segment arterial occlusive disease: the IDEAS randomized controlled trial.
Topics: Aged; Aged, 80 and over; Amputation, Surgical; Angiography, Digital Subtraction; Angioplasty, Balloon; Cardiovascular Agents; Coated Materials, Biocompatible; Constriction, Pathologic; Drug-Eluting Stents; Female; Greece; Humans; Limb Salvage; Male; Middle Aged; Paclitaxel; Peripheral Arterial Disease; Popliteal Artery; Prospective Studies; Prosthesis Design; Recurrence; Time Factors; Treatment Outcome; Vascular Access Devices; Vascular Patency; Vascular Remodeling | 2014 |
Fractional flow reserve-guided coronary angioplasty using paclitaxel-coated balloons without stent implantation: feasibility, safety and 6-month results by angiography and optical coherence tomography.
Topics: Aged; Angioplasty, Balloon, Coronary; Cardiac Catheterization; Cardiac Catheters; Cardiovascular Agents; Coated Materials, Biocompatible; Coronary Angiography; Coronary Artery Disease; Coronary Vessels; Equipment Design; Feasibility Studies; Female; Fractional Flow Reserve, Myocardial; Germany; Humans; Male; Middle Aged; Paclitaxel; Predictive Value of Tests; Prospective Studies; Time Factors; Tomography, Optical Coherence; Treatment Outcome; Vascular Remodeling | 2017 |
10 other study(ies) available for paclitaxel and Pulmonary Arterial Remodeling
| Article | Year |
|---|---|
Candidates for smart cardiovascular medical device coatings: A comparative study with endothelial and smooth muscle cells.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Cell Line; Cell Proliferation; Cell Survival; Citric Acid; Drug-Eluting Stents; Endothelial Cells; Endothelium, Vascular; Humans; Mice; Myocytes, Smooth Muscle; Paclitaxel; Thrombosis; Vascular Remodeling | 2021 |
Assessment of Vascular Patency and Inflammation with Intravascular Optical Coherence Tomography in Patients with Superficial Femoral Artery Disease Treated with Zilver PTX Stents.
Topics: Aged; Aged, 80 and over; Alloys; Angioplasty, Balloon; Cardiovascular Agents; Drug-Eluting Stents; Female; Femoral Artery; Humans; Inflammation; Male; Middle Aged; Neointima; Paclitaxel; Peripheral Arterial Disease; Predictive Value of Tests; Prospective Studies; Prosthesis Design; Risk Factors; Self Expandable Metallic Stents; Time Factors; Tomography, Optical Coherence; Treatment Outcome; Vascular Patency; Vascular Remodeling | 2020 |
Study on the Role of Paclitaxel Nano-Drug Delivery System in Inhibiting Intimal Hyperplasia and Improving Vascular Remodeling in Abdominal Aortic Injury Model.
Topics: Animals; Antineoplastic Agents, Phytogenic; Endothelial Cells; Hyperplasia; Nanoparticles; Paclitaxel; Rabbits; Vascular Remodeling | 2021 |
Vascular Response of a Polymer-Free Paclitaxel-Coated Stent (Zilver PTX) versus a Polymer-Coated Paclitaxel-Eluting Stent (Eluvia) in Healthy Swine Femoropopliteal Arteries.
Topics: Animals; Cardiovascular Agents; Drug-Eluting Stents; Endovascular Procedures; Femoral Artery; Neointima; Paclitaxel; Polymers; Prosthesis Design; Swine; Swine, Miniature; Time Factors; Vascular Remodeling; Wound Healing | 2021 |
Mesenchymal-epithelial Transition and Tumor Vascular Remodeling in Eribulin Chemotherapy for Breast Cancer.
Topics: Antigens, Neoplasm; Antineoplastic Agents; Biomarkers, Tumor; Cadherins; Carbonic Anhydrase IX; Cell Hypoxia; Epithelial-Mesenchymal Transition; Female; Furans; Humans; Ketones; Middle Aged; Paclitaxel; Retrospective Studies; Triple Negative Breast Neoplasms; Vascular Remodeling; Vimentin | 2018 |
Near-infrared optical imaging of cancer vascular remodeling after antiangiogenic therapy.
Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Female; Hemoglobins; Humans; Mammary Glands, Human; Middle Aged; Neovascularization, Pathologic; Paclitaxel; Spectrophotometry, Infrared; Triple Negative Breast Neoplasms; Vascular Remodeling | 2014 |
Contrast stainings outside the stents of the superficial femoral artery after polymer-free drug-eluting peripheral stents implantation.
Topics: Aged; Angiography; Drug-Eluting Stents; Femoral Artery; Humans; Male; Paclitaxel; Tomography, Optical Coherence; Ultrasonography, Interventional; Vascular Remodeling | 2015 |
Pro-proliferative and inflammatory signaling converge on FoxO1 transcription factor in pulmonary hypertension.
Topics: Adult; Animals; Apoptosis; Bone Morphogenetic Proteins; Bromodeoxyuridine; Cell Proliferation; Cytokines; Female; Forkhead Transcription Factors; Gene Deletion; Gene Expression Regulation; Humans; Hypertension, Pulmonary; Intercellular Signaling Peptides and Proteins; Lung; Male; Mice; Muscle, Smooth, Vascular; Paclitaxel; Pulmonary Artery; Quinolones; Rats; RNA, Messenger; Signal Transduction; Small Molecule Libraries; Vascular Remodeling | 2014 |
Local paclitaxel induces late lumen enlargement in coronary arteries after balloon angioplasty.
Topics: Aged; Angioplasty, Balloon, Coronary; Cardiac Catheters; Cardiovascular Agents; Coated Materials, Biocompatible; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Coronary Vessels; Female; Humans; Hyperplasia; Male; Middle Aged; Neointima; Paclitaxel; Retrospective Studies; Time Factors; Treatment Outcome; Vascular Remodeling | 2015 |
Targeted inhibitory effect of Lenti-SM22alpha-p27-EGFP recombinant lentiviral vectors on proliferation of vascular smooth muscle cells without compromising re-endothelialization in a rat carotid artery balloon injury model.
Topics: Animals; Antineoplastic Agents, Phytogenic; Balloon Occlusion; Carotid Arteries; Cell Proliferation; Cells, Cultured; Cyclin-Dependent Kinase Inhibitor p27; Endothelium, Vascular; G1 Phase Cell Cycle Checkpoints; Green Fluorescent Proteins; Lentivirus; Male; Microfilament Proteins; Muscle Proteins; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Neointima; Paclitaxel; Rats, Wistar; Vascular Remodeling; Wound Healing | 2015 |